Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$820M |
| 2 |
Palo Alto Networks
PANW
|
+$358M |
| 3 |
Visa
V
|
+$355M |
| 4 |
CELG
Celgene Corp
CELG
|
+$339M |
| 5 |
Citigroup
C
|
+$325M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$722M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$356M |
| 3 |
Alibaba
BABA
|
+$345M |
| 4 |
EOG Resources
EOG
|
+$344M |
| 5 |
Canadian Pacific Kansas City
CP
|
+$321M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.08% |
| 2 | Consumer Discretionary | 17.25% |
| 3 | Communication Services | 14.3% |
| 4 | Technology | 13.13% |
| 5 | Financials | 9.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
551
CALL
Standard BioTools
LAB
$351M
| $4.05M | ﹤0.01% |
+500,000
| New | +$7.87M |
|
552
ExxonMobil
XOM
$651B
| $3.94M | ﹤0.01% |
53,016
-1,681
| -3% | -$130K |
|
|
AEUA
553
DELISTED
Anadarko Petroleum Corporation
AEUA
| $3.81M | ﹤0.01% |
101,700
+41,700
| +70% | +$1.93M |
|
|
ETP
554
DELISTED
Energy Transfer Partners, L.P.
ETP
| $3.73M | ﹤0.01% |
130,040
+71,104
| +121% | +$2.41M |
|
|
BLUE
555
PUT
DELISTED
bluebird bio
BLUE
| $3.68M | ﹤0.01% |
+3,320
| New | +$6.05M |
|
556
USA Compression Partners
USAC
$3.79B
| $3.67M | ﹤0.01% |
254,706
+58,804
| +30% | +$1.08M |
|
|
ANDV
557
DELISTED
Andeavor
ANDV
| $3.55M | ﹤0.01% |
+36,532
| New | +$3.55M |
|
|
INNL
558
DELISTED
Innocoll Holdings plc Ordinary Shares
INNL
| $3.51M | ﹤0.01% |
277,048
+864
| +0.3% | +$11.9K |
|
|
RMP
559
DELISTED
Rice Midstream Partners LP
RMP
| $3.49M | ﹤0.01% |
262,294
+128,696
| +96% | +$2.04M |
|
560
Elevance Health
ELV
$81.6B
| $3.36M | ﹤0.01% |
+24,016
| New | +$3.61M |
|
561
IBM
IBM
$209B
| $3.33M | ﹤0.01% |
24,057
+1,132
| +5% | +$167K |
|
|
BNY
562
Bank of New York Mellon
BNY
$106B
| $3.29M | ﹤0.01% |
+83,992
| New | +$3.49M |
|
563
CSX Corp
CSX
$93B
| $3.27M | ﹤0.01% |
+364,677
| New | +$3.58M |
|
564
Johnson & Johnson
JNJ
$617B
| $3.26M | ﹤0.01% |
+34,969
| New | +$3.38M |
|
|
EPZM
565
DELISTED
Epizyme, Inc
EPZM
| $3.26M | ﹤0.01% |
253,668
+1,551
| +0.6% | +$31.3K |
|
566
Blackrock
BLK
$170B
| $3.25M | ﹤0.01% |
10,942
+892
| +9% | +$288K |
|
567
Brink's
BCO
$4.84B
| $3.23M | ﹤0.01% |
119,606
-1,041,888
| -90% | -$29.9M |
|
568
Berkshire Hathaway Class B
BRK.B
$1.1T
| $3.22M | ﹤0.01% |
24,694
+993
| +4% | +$136K |
|
569
RTX Corp
RTX
$289B
| $3.19M | ﹤0.01% |
57,034
-512,006
| -90% | -$31.5M |
|
570
Markel Group
MKL
$23.6B
| $3.17M | ﹤0.01% |
+3,952
| New | +$3.34M |
|
|
SRRA
571
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
| $3.09M | ﹤0.01% |
+3,760
| New | +$4.24M |
|
572
eBay
EBAY
$50.4B
| $3.05M | ﹤0.01% |
+124,915
| New | +$3.36M |
|
573
Tyson Foods
TSN
$21.4B
| $2.98M | ﹤0.01% |
+69,097
| New | +$2.95M |
|
574
Cummins
CMI
$87.3B
| $2.95M | ﹤0.01% |
27,187
+22,877
| +531% | +$2.83M |
|
|
HSTO
575
DELISTED
Histogen Inc. Common Stock
HSTO
| $2.93M | ﹤0.01% |
3,295
+20
| +0.6% | +$18.2K |
|
Similar funds
Jennison Associates's Q3 2015 Portfolio in Review
As of Q3 2015, Jennison Associates held 813 positions worth $97.6B, down 11% from $109B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Jennison Associates's Q3 2015 filing shows 84 new, 272 increased, 353 reduced and 92 closed positions. Its largest new stake was Palo Alto Networks: 12,124,434 shares worth $348M. The largest sale was Gilead Sciences, an estimated $722M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Communication Services.
- Jennison Associates's largest Q3 2015 buy was Palo Alto Networks: 12,124,434 shares worth $348M.
- Jennison Associates added most to Alphabet (Google) Class C in Q3 2015, an estimated $820M increase.
- Jennison Associates's biggest Q3 2015 reduction was Gilead Sciences, cutting an estimated $722M.
- Jennison Associates fully exited KRAFT FOODS GROUP INC COM STK (VA) in Q3 2015, selling an estimated $144M.
- Jennison Associates's ten largest holdings make up 24% of its $97.6B portfolio in Q3 2015.
- Jennison Associates opened 84 new positions and closed 92 in Q3 2015.
- Jennison Associates's portfolio value fell 11% quarter-over-quarter to $97.6B.
Based on Jennison Associates's 13F filing for Q3 2015, filed 6 Nov 2015.